- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01916876
Impact of Medical Follow-up Discharge Package (RECALL-CT)
A Randomised Controlled Trial of an Integrated Post-discharge Transitional Care Package for General Medical In-patients in Cape Town, South Africa
The post discharge time is a vulnerable time for general medical in-patients, with high rates of adverse events that may cause unnecessary readmissions and even death. A recent study of 415 patients discharged from the general medical wards at Groote Schuur Hospital, demonstrated a very high 12 month mortality of 35%. The majority of these deaths were classified as "unexpected". The reasons for this were not further examined, but it was speculated, given the authors' knowledge of the public sector in Cape Town, that three related factors contribute significantly to this early mortality: i) a lack of continuity of care, with patients not necessarily accessing the primary care support treatment that they need or being able to access early post discharge follow-up (for example for anti-retroviral or anti-tuberculous care); ii) the inability of primary care to deal with the complex nature of the discharged patients, most whom have significant co-morbid disease; iii) A lack of optimisation of therapy for chronic disease after acute discharge.
The investigators hypothesise that an integrated post-discharge transitional care package, which includes an early medical specialist follow-up in the first 3 months after hospital discharge will decrease the 6- and 12-month mortality and re-admission rate amongst general medical hospital admissions in Cape Town, South Africa. Our study will compare an integrated package, suitable to implementation if effective, with current standard discharge packages.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Cape Town, South Africa, 8001
- Groote Schuur Hospital
-
Cape Town, South Africa, 8001
- Victoria Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients referred for admission to general medical wards (including within hospital transfer e.g. ICU discharge)
- >18 years and willing to give informed consent
Exclusion Criteria:
- Patient admitted directly to intensive care unit
- Patient refusing consent or <18 years old
- Patients electively admitted
- Patients without phone numbers who cannot provide any telephone contact details for a co-habitant, relative or neighbour.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Standard Care
At discharge, patients will be given a discharge plan by their attending caregiver as deemed appropriate.
|
|
Other: Integrative medical follow-up package
At discharge, patients will receive a discharge plan by their attending caregiver. Thereafter, if randomised to this study arm they will receive the intervention as outlined elsewhere. "Integrated Medical Follow-up package" |
At discharge, patients will receive a discharge plan by their attending caregiver.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cause mortality
Time Frame: 12 months
|
All cause 12-month mortality will be evaluated at 12-months post enrolment.
Data on mortality will be acquired through telephonic patient/family contact and review of provincial death registry
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
All cause mortality
Time Frame: 6 months
|
6-month mortality will be evaluated in a similar way to 12-month mortality.
|
6 months
|
Hospital readmission rate
Time Frame: 12 months
|
Readmission to secondary, tertiary hospitals or emergency units will be included.
|
12 months
|
Bartel index
Time Frame: 12 months
|
The change in functional outcome between discharge and 12-months will be measured using the Bartel index.
|
12 months
|
Karnofsky performance score
Time Frame: 12 months
|
Changes in functional outcomes will be assessed by measuring the change in Karnofsky performance scores between 12-months and pre-admission.
|
12 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jonathan Peter, University of Cape Town
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- UCT 148.2/2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Follow-up Study
-
Aesculap AGCompleted
-
Ruhr University of BochumNot yet recruitingOne Week Follow-up Assessment | Six Weeks Follow-up Assessment | Three Months Follow-up AssessmentGermany
-
HealthpointCompletedFollow up to Acute Wound Scar StudyUnited States
-
University of PennsylvaniaCompleted
-
Spinal KineticsEnrolling by invitation
-
Sorrento Therapeutics, Inc.Enrolling by invitationLong-term Follow-upUnited States
-
University Hospital, AntwerpRecruitingEducation | Mobile Health | Follow-upBelgium
-
Planned Parenthood League of MassachusettsSociety of Family PlanningCompletedFollow-up After Uterine EvacuationUnited States
-
Vanderbilt University Medical CenterCompleted
-
Peking University Third HospitalCompletedFollow-up Time, Postoperative Knee Joint Score, Postoperative X-ray, Follow-up Postural Image DataChina
Clinical Trials on Integrated medical follow-up package
-
Jessa HospitalTerminatedChronic Heart FailureBelgium
-
Federico II UniversityCompletedHodgkin Lymphoma | Relapse | High Risk
-
M.D. Anderson Cancer CenterRecruitingCervical Large Cell Neuroendocrine Carcinoma | Cervical Neuroendocrine Carcinoma | Cervical Small Cell Carcinoma | Cervical Undifferentiated Carcinoma | Stage I Cervical Cancer AJCC v8 | Stage IA Cervical Cancer AJCC v8 | Stage IA1 Cervical Cancer AJCC v8 | Stage IA2 Cervical Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Diakonhjemmet HospitalSt. Olavs HospitalCompleted
-
Emilia Falcone, MDRecruiting
-
ElsanCemka-EvalWithdrawnBariatric Surgery CandidateFrance
-
Vejle HospitalCompleted
-
Butler HospitalNational Institute of Mental Health (NIMH)Enrolling by invitationBipolar Disorder | Substance Use DisordersUnited States
-
Istanbul University - Cerrahpasa (IUC)CompletedInfertility | Psychological Distress | Infertility, Female | Depression, Anxiety | Nurse's RoleTurkey
-
Hospital Universitario 12 de OctubreConsorcio Centro de Investigación Biomédica en Red (CIBER)Recruiting